Ameritas Investment Partners’s Enzo Biochem, Inc. ENZ Stock Holding History

Ameritas Investment Partners’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,092	Closed	-$11K	–	3254
2021 Q1	$11K	Hold	3,092	–	–	﹤0.01%	2825
2020 Q4	$8K	Hold	3,092	–	–	﹤0.01%	2893
2020 Q3	$7K	Hold	3,092	–	–	﹤0.01%	2892
2020 Q2	$7K	Hold	3,092	–	–	﹤0.01%	2894
2020 Q1	$8K	Hold	3,092	–	–	﹤0.01%	2654
2019 Q4	$8K	Hold	3,092	–	–	﹤0.01%	2815
2019 Q3	$11K	Hold	3,092	–	–	﹤0.01%	2719
2019 Q2	$10K	Hold	3,092	–	–	﹤0.01%	2811
2019 Q1	$8K	Hold	3,092	–	–	﹤0.01%	2776
2018 Q4	$9K	Hold	3,092	–	–	﹤0.01%	2719
2018 Q3	$13K	Hold	3,092	–	–	﹤0.01%	2740
2018 Q2	$16K	Hold	3,092	–	–	﹤0.01%	2636
2018 Q1	$17K	Hold	3,092	–	–	﹤0.01%	2503
2017 Q4	$25K	Hold	3,092	–	–	﹤0.01%	2340
2017 Q3	$34K	Hold	3,092	–	–	﹤0.01%	2112
2017 Q2	$34K	Hold	3,092	–	–	﹤0.01%	2155
2017 Q1	$26K	Buy	+3,092	New	+$21.8K	﹤0.01%	2269

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCA

VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameritas Investment Partners's ENZ Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Enzo Biochem, Inc. (ENZ) in Q2 2021, closing a stake of 3,092 shares — an estimated $11K sold.

Ameritas Investment Partners first reported a position in ENZ in Q1 2017 and held it in 17 quarters. The position peaked at $34K in Q3 2017. 72 funds tracked by Wall St. Rank hold ENZ as of Q2 2021.

Ameritas Investment Partners reported no remaining Enzo Biochem, Inc. position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Partners sold 3,092 Enzo Biochem, Inc. shares in Q2 2021, an estimated $11K.
Ameritas Investment Partners first reported a position in Enzo Biochem, Inc. in Q1 2017 and held it in 17 quarters.
Ameritas Investment Partners's Enzo Biochem, Inc. position peaked at $34K in Q3 2017.
72 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.